Case Control in Sarcopenia Among Elderly Type 2 Diabetic Patients

NCT07244601 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-19

No results posted yet for this study

Summary

1. Assess sarcopenia prevalence in elderly diabetic patients.
2. Evaluate impact of diabetes and its medications on muscle health.
3. detect effect of sacropenia on quality of life on elderly

Conditions

Interventions

DIAGNOSTIC_TEST

muscle ultrasound

Bedside muscle ultrasound to measure muscle thickness, cross-sectional area and echogenicity

Sponsors & Collaborators

  • Eman Alaa Eldean Mohamed

    lead OTHER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-22
Primary Completion
2027-10-20
Completion
2028-10-20
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07244601 on ClinicalTrials.gov